News and Events

Upcoming Events
May 19, 2025
May 29 Joint Finance/Science Subcommittee Meeting
May 19, 2025
May 29 Application Review Subcommittee Meeting
April 18, 2025
April 30 Accessibility and Affordability Working Group Meeting
April 18, 2025
April 29 Grants Working Group Meeting
Latest Press Releases
April 24, 2025
CIRM awards $8 million to advance vision loss gene therapy to clinical trials
March 27, 2025
CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
January 31, 2025
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
November 21, 2024
CIRM Awards $29.7 Million to Advance Clinical Projects
CIRM’s Blog: The Stem Cellar
The Stem Cellar
- Gene Therapy for Osteoarthritis Shows Positive Results in Early Trial May 19, 2025Here’s a shocking statistic: in 2020, 7.6% of the world’s population was living with the most common form of arthritis – osteoarthritis (OA). That amounts to 595 million people globally and 32.5 million adults in the U.S. That’s a lot of people with painful knees, hips, and other joints. Although pain medication can help with […]
- 20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration May 12, 2025In celebration of CIRM’s 20th anniversary, we are reflecting on some of the early projects we supported that have since advanced to clinical trials. One such trial for a form of blindness originated with a 2007 SEED grant to David Hinton, MD, of the University of Southern California (USC) and later with a 2008 Disease […]
- New gene therapy aims to restore function in early-onset Parkinson’s April 25, 2025Nearly one million people in the U.S. are living with Parkinson’s disease, which causes progressive symptoms including tremors, stiffness, and gait and balance issues. Although there are medications to treat symptoms, the disease has no cure. To date, the California Institute for Regenerative Medicine (CIRM) has invested more than $109 million in helping research for […]